Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
This review illustrates the recent understanding of amyloid-β oligomers' characteristics and toxicity-related pathways, along with inhibitors against Aβ aggregation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ plaques are accumulations of sticky Aβ peptides outside of the neurons and impede the synaptic communication between neurons, leading to neuronal death.”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Aβ peptides are formed by proteolytic cleavage of the amyloid precursor protein (APP), specifically the hydrophobic transmembrane portion, by β- and γ-secretases [3].”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Soluble Aβ oligomers are the primary neurotoxic substances,131–133”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [133]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 301–400 of 577
Singh, A., Rakshit, D., Kumar, A., Mishra, A., & Shukla, R. (2023) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2023.2230857 · Cited by 15
“These aggregates mostly accumulate at extra-neuronal locations as a result of increased Aβ deposition and decreased clearance from brain [2].”
BackgroundA Unified View of Assessing the Pro‐oxidant versus Antioxidant Nature of Amyloid Beta Conformers
Mitra, S., Prasad, P., & Chakraborty, S. (2018) · ChemBioChem · doi:10.1002/cbic.201800446 · Cited by 13
Iida, M., Mashima, T., Yamaoki, Y., So, M., Nagata, T., & Katahira, M. (2019) · FEBS Journal · doi:10.1111/febs.14819 · Cited by 13
Kopeć, K., Koziorowski, D., & Szlufik, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157552 · Cited by 15
“These molecules exert toxicity through many different mechanisms and induce synaptic loss in AD [17,47,48].”
A new therapeutic perspective on metal-based drugs
Castro-Ramírez, R., & Barba-Behrens, N. (2025) · Dalton Transactions · doi:10.1039/d5dt01567g · Cited by 13
An, Y., Jiang, D., Zhang, N., & Jiang, W. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340440 · Cited by 13
Nam, E., Lin, Y., Park, J., Do, H., Han, J., Jeong, B., Park, S., Lee, D. Y., Kim, M., Han, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202307182 · Cited by 13
Self-citationHossen, F., Geng, X. H., Sun, G. Y., Yao, X., & Lee, J. C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04138-z · Cited by 13
“…treated group; ФФ p < 0.001 compared to the oTau treated group; and ¥¥¥ p < 0.001, δδ p < 0.01, δ p < 0.05 compared to the oAβ + oTau treated group to be the most cytotoxic [121]. oAβ can induce alternation of the neuronal signaling and proteomes, ultimately leading to neurodegeneration [122, 123].”
InfluentialMelo, L., Silva, A. M. S., & Albuquerque, H. M. T. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117874 · Cited by 16
Interactions with tau’s microtubule-binding repeats modulate amyloid-β aggregation and toxicity
Kim, M., Lin, Y., Nam, E., Kang, D. M., Lim, S., Kim, Y. K., Lee, Y., & Lim, M. H. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01987-0 · Cited by 17
Self-citationProbing the Occurrence of Soluble Oligomers through Amyloid Aggregation Scaling Laws
Silva, A., Sárkány, Z., Fraga, J. S., Taboada, P., Macedo‐Ribeiro, S., & Martins, P. M. (2018) · Biomolecules · doi:10.3390/biom8040108 · Cited by 12
“species ranging from protein dimers to complex n-mers [7,8].”
BackgroundTotal synthesis, stereochemical assignment, and biological evaluation of L-755,807
Tanaka, K., Honma, Y., Yamaguchi, C., Aoki, L., Saito, M., Suzuki, M., Arahata, K., Kinoshita, K., Koyama, K., Kobayashi, K., et al. (2019) · Tetrahedron · doi:10.1016/j.tet.2019.01.020 · Cited by 12
β-Amyloid peptide interactions with biomimetic membranes: A multiparametric characterization
Smeralda, W., Since, M., Cardin, J., Corvaisier, S., Lecomte, S., Cullin, C., & Malzert‐Fréon, A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.107 · Cited by 12
Chiroplasmon-active optical fiber probe for environment chirality estimation
Miliutina, E., Žádný, J., Guselnikova, O., Storch, J., Walaska, H., Kushnarenko, A., Burtsev, V., Švorčı́k, V., & Lyutakov, O. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130122 · Cited by 12
Organoplatinum‐Substituted Polyoxometalate Inhibits β‐amyloid Aggregation for Alzheimer's Therapy
Zhao, J. W., Li, K., Wan, K., Sun, T., Zheng, N., Zhu, F., Ma, J., Jiao, J., Li, T., Ni, J., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201910521 · Cited by 12
Lee, H. J., Savelieff, M. G., Kang, J., Brophy, M. B., Nakashige, T. G., Lee, S. J. C., Nolan, E. M., & Lim, M. H. (2018) · Metallomics · doi:10.1039/c8mt00091c · Cited by 16
Self-citationMa, L., Zheng, J., Chen, H., Zeng, X., Wang, S., Yang, C., Li, X., Xiao, Y., Zheng, L., Chen, H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.637766 · Cited by 15
Abidi, S. M. S., Dar, A. I., & Acharya, A. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00228 · Cited by 12
Autoxidation Enhances Anti-Amyloid Potential of Flavone Derivatives
Sakalauskas, A., Žiaunys, M., Sniečkutė, R., & Smirnovas, V. (2021) · Antioxidants · doi:10.3390/antiox10091428 · Cited by 12
A protocol for quantitative analysis of murine and human amyloid-β1-40 and 1-42
Illouz, T., Madar, R., Griffioen, K. J. S., & Okun, E. (2017) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2017.07.022 · Cited by 14
Berntsson, E., Vosough, F., Noormägi, A., Padari, K., Asplund, F., Gielnik, M. B., Paul, S., Jarvet, J., Tõugu, V., Roos, P. M., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00130 · Cited by 12
“7 Synthetic lyophilized wildtype (wt) Aβ(1-42) peptides, abbreviated as Aβ42, with the primary sequence DAEFR5HDSGY10EVHHQ15KLVFF20AEDVG25SNKGA30IIGLM35VGGVV40IA, were purchased from JPT Peptide Technologies (Germany).”
MethodLight‐controlled molecular tweezers capture specific amyloid oligomers
Qian, C., Chen, J., Gao, F., Xian, T., Wang, X., Wang, X., Wang, X., & Wang, X. (2023) · Aggregate · doi:10.1002/agt2.463 · Cited by 11
Distinct Aggregation Behavior of N-Terminally Truncated Aβ4–42 Over Aβ1–42 in the Presence of Zn(II)
Na, C., Kim, M., Kim, G., Lin, Y., Lee, Y., Bal, W., Nam, E., & Lim, M. H. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00831 · Cited by 11
Self-citationYoung, K. Z., Cartee, N. M. P., Ivanova, M. I., & Wang, M. M. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113261 · Cited by 11
He, H., Xu, J., Li, C., Gao, T., Jiang, P., Jiang, F., & Liu, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100436 · Cited by 11
Zheng, Y., Zhao, J., Zhang, L., & Wang, W. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.133418 · Cited by 11
Tan, R., Li, W., Pang, J.-M., Zhong, S.-M., Huang, X.-Y., Deng, J.-Z., Zhou, L., Wu, J., & Wang, X. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10651-5 · Cited by 12
Rationally designed cyclic peptides and nanomaterials as ‘next-generation’ anti-amyloid therapeutics
Khairnar, B. D., Jha, A., & Rajwade, J. M. (2023) · Journal of Materials Science · doi:10.1007/s10853-023-08654-6 · Cited by 12
“Targeted amyloid inhibitors were designed based on these recognition motifs [28].”
BackgroundKaur, A., & Goyal, B. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108558 · Cited by 11
Singh, V. K., Kumar, S., & Tapryal, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c00730 · Cited by 11
“A recent study, where the oligomeric species were found to be more toxic compared to the fi brils, 50 suggests that non fi bril structures are potent toxins.”
Wu, K. Y., Doan, D., Medrano, M. L. T., & Chang, C. A. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1939163 · Cited by 13
Strategies for Inhibition and Disaggregation of Amyloid‐β Fibrillation
Geng, H., Gao, D. M., Wang, Z., Liu, X., Cao, Z., & Xing, C. (2021) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202100646 · Cited by 10
Chen, D., Chen, Q., Qin, X., Tong, P., Peng, L., Zhang, T., & Xia, C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1209863 · Cited by 11
“Compelling evidence showed that the highly hydrophobic and aggregation-prone Aβ1−40/42 plays an upstream role in the pathological progression of AD via inducing tau hyperphosphorylation, synaptic dysfunction, and neuroinflammation (Selkoe and Hardy, 2016; Lee et al., 2017).”
BackgroundTransition Metal Ion FRET-Based Probe to Study Cu(II)-Mediated Amyloid-β Ligand Binding
Wu, R., Svingou, D., Metternich, J. B., Benzenberg, L. R., & Zenobi, R. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c11533 · Cited by 11
A Novel Drosophila Model of Alzheimer’s Disease to Study Aβ Proteotoxicity in the Digestive Tract
Elovsson, G., Klingstedt, T., Brown, M., Nilsson, K. P. R., & Brorsson, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042105 · Cited by 12
“Inhibiting the aggregation process could indeed be an effective therapeutic strategy, since oligomeric species are highly associated with proteotoxicity [39].”
BackgroundThe Promising Role of Selenium and Yeast in the Fight Against Protein Amyloidosis
Kieliszek, M., & Sapazhenkava, K. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04245-x · Cited by 10
“Amyloid monomers and oligomers may have a direct toxic effect on cell viability [11, 12].”
DNA-based nanostructures for cell membrane receptor regulation and disease treatment
Cheng, Z., Liu, Y., Chen, Q., Tan, Y., Man, Y., Zhang, Z., Du, S., Lv, Z., Wang, Q., Shao, K., et al. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115674 · Cited by 11
Promoted Aggregation of Aβ on Lipid Bilayers in an Open Flowing System
Iida, A., Abe, M., Nochi, M., Soga, C., Unoura, K., & Nabika, H. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c00524 · Cited by 10
Chen, L., Zhou, Z., Zhang, Y., Pan, J., Wang, K., & Wang, H. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00372d · Cited by 10
Lee, D.-H., Ryoo, J. E., Hong, S., Kim, H. Y., & Kim, Y. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-36167-4 · Cited by 12
Hayward, S., & Milner‐White, E. J. (2021) · Journal of Structural Biology · doi:10.1016/j.jsb.2021.107738 · Cited by 10
“The aggregation of proteins into a fibrillar conformation composed largely of β-sheet termed amyloid is the cause of many different diseases including Alzheimer’s Disease, Parkinson’s Disease, type II diabetes and Huntington’s Disease (Chiti and Dobson, 2017; Eisenberg and Jucker, 2012; Erskine et al., 2018; Lee et al…”
BackgroundDrommi, M., Rulmont, C., Esmieu, C., & Hureau, C. (2021) · Molecules · doi:10.3390/molecules26247630 · Cited by 11
Saini, M., & Sadhu, K. K. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127086 · Cited by 11
Inorganic ion-sensitive imaging probes for biomedical applications
Wang, Q., Wang, P., Huang, C., Cui, S., Yang, S., Li, F., & Ling, D. (2023) · Chemical Communications · doi:10.1039/d3cc00418j · Cited by 10
Jarero-Basulto, J. J., Gasca-Martínez, Y., Rivera-Cervantes, M. C., Gasca‐Martínez, D., González, N., Beas‐Zárate, C., & Gudiño‐Cabrera, G. (2024) · NeuroSci · doi:10.3390/neurosci5020010 · Cited by 12
“Curiously, we observed that the presence of A β Os in the extracellular space seemed to be associated with the plasma membrane, but we did not investigate this finding further.”
RetractedAdvances and Challenges in Gene Therapy for Alzheimer’s Disease
Morroni, F., & Caccamo, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230783 · Cited by 13
Lakela, A. L., Berntsson, E., Vosough, F., Jarvet, J., Paul, S., Barth, A., Gräslund, A., Roos, P. M., & Wärmländer, S. K. T. S. (2025) · Scientific Reports · doi:10.1038/s41598-024-59826-6 · Cited by 13
Liu, L., Liu, W., Dong, X., & Sun, Y. P. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163063 · Cited by 9
Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
Sulatsky, M. I., Stepanenko, O. V., Stepanenko, O. V., & Sulatskaya, A. I. (2025) · Aggregate · doi:10.1002/agt2.70078 · Cited by 11
Liu, C., Wu, J., Hu, C., Yang, A., Shen, R., & Kou, X. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.112086 · Cited by 11
Murakami, K., Sakaguchi, Y., Taniwa, K., Izuo, N., Hanaki, M., Kawase, T., Hirose, K., Shimizu, T., & Irie, K. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00194b · Cited by 9
“Moreover, Raman spectroscopy has the potential for enabling on-site detection of viruses in clinical samples, although these developments are yet in embryo .”
Mu, R.-H., Hou, X., Liu, Q., Wang, W., Qin, C., & Li, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111786 · Cited by 9
Solution‐Based Determination of Dissociation Constants for the Binding of Aβ42 to Antibodies
Zhang, T., Nagel‐Steger, L., & Willbold, D. (2019) · ChemistryOpen · doi:10.1002/open.201900167 · Cited by 8
Argentati, C., Tortorella, I., Bazzucchi, M., Emiliani, C., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030115 · Cited by 11
Guo, L., & Sun, B. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00574 · Cited by 9
Liu, H., Cao, Y., Deng, Y., Wei, L., Yan, J., & Xiao, L. (2023) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.3c00081 · Cited by 9
Dey, A., Ghosh, S., Majhi, S., Hoque, A. N., & Chakrabarti, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-9462-5_20 · Cited by 8
Advances in neural stem cells in aging and age-related neurodegenerative diseases
Zhong, R., Huang, W., Chen, C., Zhang, B., Pu, J., & Zhang, F. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.32 · Cited by 11
Berntsson, E., Friedemann, M., Noormägi, A., Jarvet, J., Roos, P. M., Tõugu, V., Gräslund, A., Palumaa, P., & Wärmländer, S. K. T. S. (2022) · ACS Omega · doi:10.1021/acsomega.2c02254 · Cited by 9
Curved Nanointerface Controls the Chiral Effect on Peptide Fibrillation
Li, L., Duan, Q., Deng, Y., Ye, Z., & Xiao, L. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c11858 · Cited by 8
Liu, J., Chen, L., Zhang, Z., Wen, W., Zhang, X., Wu, Z., & Wang, S. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04598 · Cited by 8
The pro-apoptotic domain of BIM protein forms toxic amyloid fibrils
Malishev, R., Ben-Zichri, S., Oren, O., Shauloff, N., Peretz, T., Taube, R., Papo, N., & Jelinek, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03623-7 · Cited by 9
Fontana, I. C., Ferreira, P. C. L., Miron, D., Santos, L. E., Ferreira, S. T., Souza, D. O., Gosmann, G., Zimmer, E. R., & Zimmer, A. R. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462024 · Cited by 9
Fei, Z., Pan, B., Pei, R., Chen, Z., Du, X., Cao, H., & Li, C. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02115-y · Cited by 10
“due to the neurotoxicity of Aβ oligomers [61].”
BackgroundBouvet, P., Gea, P. D., Aimard, M., Chounlamountri, N., Honnorat, J., Delcros, J., Salin, P. A., & Meissirel, C. (2023) · Aging Cell · doi:10.1111/acel.13907 · Cited by 11
“…be non- toxic due to the loss of well- defined β- sheet structure (Ehrnhoefer et al., 2008) that provide Aβo the ability to bind to cell membranes and/or create calcium ion- permeable channels or pore structures (Lee et al., 2017), as those formed with annular Aβ aggregates (Lashuel et al., 2002).”
BackgroundInfluentialAmyloid-β-interacting proteins in peripheral fluids of Alzheimer’s disease
Yi, Y., Lee, J., & Lim, M. H. (2024) · Trends in Chemistry · doi:10.1016/j.trechm.2024.01.003 · Cited by 9
Self-citationNg, J. T. Y., Kamm, R. D., Wohland, T., & Kraut, R. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.030 · Cited by 8
Frigori, R. B., da Silva, F. L. B., Carvalho, P. P. D., & Alves, N. A. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c01360 · Cited by 8
Zeng, F., Li, Y., Xu, Y., Yang, J., Liu, Z., Li, X., & Ren, L. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191031163504 · Cited by 9
Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovations
López-García, P., Tejero-Ojeda, M. M., Vaquero, M. E., & Carrión‐Vázquez, M. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102734 · Cited by 8
“Others inhibitors targeting A β aggregation at preclinical stages include the molecular tweezer CLR01 (Attar et al., 2013) and the peptide D-Trp-Aib (D-Trp-Aminoisobutyric acid) (Frydman-Marom et al., 2009; Lee et al., 2017).”
Kaur, G., Mankoo, O. K., Kaur, A., Mann, S., Priyadarshi, N., Singh, P. P., Goyal, B., Singhal, N. K., & Goyal, D. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00386 · Cited by 7
Measurement of synaptic density in Down syndrome using PET imaging: a pilot study
DiFilippo, A. H., Jonaitis, E. M., Makuch, R., Piro‐Gambetti, B., Fleming, V., Ennis, G. E., Barnhart, T. E., Engle, J. W., Bendlin, B. B., Johnson, S. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54669-7 · Cited by 8
The influences of E22Q mutant on solvated 3Aβ11-40 peptide: A REMD study
Ngô, S. T., Hung, H. M., Hong, N. D., & Tùng, N. T. (2018) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2018.06.002 · Cited by 7
Rondelli, V., Salmona, M., Colombo, L., Fragneto, G., Fadda, G. C., Cantú, L., & Favero, E. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218295 · Cited by 7
“Therefore, the wealth of related literature, using both in vitro and in vivo experimental models, has addressed the toxic effect displayed by Aβ oligomers [10], with the aim of unravelling their structural properties in relation to their impact on cells.”
Sarkar, D., Maity, N. C., Shome, G., Varnava, K. G., Sarojini, V., Vivekanandan, S., Sahoo, N., Kumar, S., Mandal, A. K., Biswas, R., et al. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp01650h · Cited by 7
Qu, W., Zhang, L., Liang, X., Yu, Z., Huang, H., Zhao, J., Guo, Y., Zhou, X., Xu, S., Luo, H., et al. (2023) · Biosensors · doi:10.3390/bios13010110 · Cited by 9
“Accumulating evidence strongly supports that soluble oligomeric Aβ42, ranging from LMW to HMW, is neurotoxic [37,38].”
BackgroundYu, Z., Moshood, Y., Woźniak, M., Patel, S., Terpstra, K., Llano, D. A., Dobrucki, L. W., & Mirica, L. M. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202302408 · Cited by 7
Zhuang, Z.-M., Zhou, Z., Chen, X., Xu, X., Wang, H., & Pan, J. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c09034 · Cited by 7
Song, H., Ma, X., Xu, J., Song, Q., Meng, H., Gu, X. Q., Zhang, Q., Hou, L., Chen, L., Huang, Y., et al. (2018) · Nano Research · doi:10.1007/s12274-018-2107-8 · Cited by 7
Multifaceted Influences of Melanin‐Like Particles on Amyloid‐beta Aggregation
Song, H., Kim, Y., Kim, I., Kim, Y., Kwon, S., & Kang, K. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201901405 · Cited by 8
Zhao, Y., Li, J., Wu, Z. L., Zhang, H. E., Zhao, Y., Yang, R., & Lu, L. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.105721 · Cited by 8
Berntsson, E., Paul, S., Vosough, F., Sholts, S. B., Jarvet, J., Roos, P. M., Barth, A., Gräslund, A., & Wärmländer, S. K. T. S. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5493 · Cited by 13
Probing the interactions between amyloidogenic proteins and bio-membranes
Ma, L., Li, X., Petersen, R. B., Peng, A., & Huang, K. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.106984 · Cited by 7
Yi, Y., Han, J., Park, M., Park, N., Nam, E., Jin, H. K., Bae, J., & Lim, M. H. (2019) · Chemical Communications · doi:10.1039/c9cc01005j · Cited by 7
Self-citationYang, W., Kim, B. S., Lin, Y., Ito, D., Kim, J. H., Lee, Y., & Yu, W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.23.457317 · Cited by 7
“1 Exploring ensemble structures of Alzheimer's amyloid (1-42) monomer using linear regression for the MD simulation and NMR chemical shift”
MethodKwak, J., Yi, Y., Park, S., & Lim, M. H. (2024) · Chemical Science · doi:10.1039/d4sc06417h · Cited by 7
Self-citationChemical Strategies to Modulate Amyloidogenesis Associated with Neurodegenerative Diseases
Na, C., Jang, Y., Son, M., & Lim, M. H. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c20362 · Cited by 6
Self-citationBall, S. R., Adamson, J. S. P., Sullivan, M. A., Zimmermann, M. R., Lo, V., Sanz-Hernández, M., Jiang, X., Kwan, A. H., McKenzie, A. D. J., Werry, E. L., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00498 · Cited by 6
“Many groups have demonstrated that soluble intermediate species formed by Aβ42 in vitro are neurotoxic 1, 5, 37, 38 .”
Fang, D., Pan, D., Wen, X., Zhang, J., Yang, M., Ye, D., & Liu, H. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00377 · Cited by 6
Gonçalves, P. B., Cordeiro, Y., & Sodero, A. C. R. (2024) · RSC Advances · doi:10.1039/d4ra03343d · Cited by 8
“39 Additionally, oligomers can also be released by mature brils a er their formation.”
Wu, T., Zhang, X., Cai, S., Zhang, W., & Yang, R. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114369 · Cited by 7
Electrical characteristics of amyloid beta peptides in vertical junctions
Seo, S., Lee, J., Choi, J., Park, G. H., Hong, Y., & Lee, H. (2021) · NPG Asia Materials · doi:10.1038/s41427-021-00321-z · Cited by 6
Self-citationRational Design of a Cu Chelator That Mitigates Cu‐Induced ROS Production by Amyloid Beta
Mitra, S., Talukdar, K., Prasad, P., Misra, S. K., Khan, S. I., Sharp, J. S., Jurss, J. W., & Chakraborty, S. (2021) · ChemBioChem · doi:10.1002/cbic.202100485 · Cited by 6
Ferdosh, S., Banerjee, S., Singh, J., & Barat, C. (2022) · FEBS Letters · doi:10.1002/1873-3468.14308 · Cited by 7
Zunyimycin C enhances immunity and improves cognitive impairment and its mechanism
Wang, X., Li, Z., Sun, R. X., Li, X., Guo, R., Cui, X., Liu, B., Li, W., Yang, Y., Huang, X., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1081243 · Cited by 7
Cantillon, M., Andreasen, N. C., & Prins, N. D. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.2 · Cited by 7
Active Site Environment and Reactivity of Copper‐Aβ in Membrane Mimetic SDS Micellar Environment
Dey, C., Roy, M., Ghosh, R., Pal, P., Roy, D., & Dey, S. G. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202401531 · Cited by 6
Changes of the Primary Cilia in Alzheimer's Disease Pathogenesis
Guo, A., Wang, H., Zhang, Y., & Huang, H. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70125 · Cited by 7
Wei, Z., Dong, X., & Sun, Y. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c10137 · Cited by 5
Fu, Y., Zhang, J., Yang, C., Wang, Y., Yang, Y., Qiu, P., Xie, W., Zhang, S., & Lǚ, T. (2025) · International Journal of Toxicology · doi:10.1177/10915818251338235 · Cited by 6
Metadata
- Authors
- Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H.
- Affiliations
- Ulsan National Institute of Science and Technology (KR)
- University of Michigan (US)
- Corresponding author
- Lim, Mi Hee
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 46
- Issue
- 2
- Pages
- 310-323
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2550762885
- Cited by
- 576
- References
- 51
- Citations by year
- 2026: 38 · 2025: 69 · 2024: 72 · 2023: 75 · 2022: 66 · 2021: 78 · 2020: 60 · 2019: 54 · 2018: 45 · 2017: 18
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, amyloid-beta aggregation, amyloid fibril formation, amyloidosis, amyloid-beta clearance
- MeSH terms
- Alzheimer Disease, Humans, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.